S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:CRVS

Corvus Pharmaceuticals News Headlines

$2.91
-0.26 (-8.20 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.82
Now: $2.91
$3.21
50-Day Range
$3.17
MA: $3.85
$4.77
52-Week Range
$1.01
Now: $2.91
$6.88
Volume1.55 million shs
Average Volume1.12 million shs
Market Capitalization$81.66 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Headlines

Corvus Pharmaceuticals (NASDAQ CRVS) News Headlines Today

Source:
SourceHeadline
Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 8.2%Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 8.2%
americanbankingnews.com - March 4 at 8:44 PM
 Analysts Anticipate Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Will Announce Earnings of -$0.32 Per Share Analysts Anticipate Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Will Announce Earnings of -$0.32 Per Share
americanbankingnews.com - February 28 at 4:16 AM
Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 11.6%Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 11.6%
americanbankingnews.com - February 23 at 8:32 PM
Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Up 21.5% Following Insider Buying ActivityCorvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Up 21.5% Following Insider Buying Activity
americanbankingnews.com - February 22 at 6:19 PM
Corvus Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:CRVS)Corvus Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:CRVS)
americanbankingnews.com - February 22 at 3:53 PM
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Director Purchases $4,499,999.00 in StockCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Director Purchases $4,499,999.00 in Stock
americanbankingnews.com - February 19 at 6:32 PM
Co-Founder Richard Miller Just Bought 8.5% More Shares In Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)Co-Founder Richard Miller Just Bought 8.5% More Shares In Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
finance.yahoo.com - February 19 at 7:47 AM
Richard A. Md Miller Buys 100,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) StockRichard A. Md Miller Buys 100,000 Shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Stock
americanbankingnews.com - February 17 at 9:12 PM
Corvus Pharmaceuticals Announces Closing of Public Offering of Common StockCorvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
finance.yahoo.com - February 17 at 6:15 PM
Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Gap Down to $3.94Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Gap Down to $3.94
americanbankingnews.com - February 12 at 11:20 AM
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common StockCorvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - February 12 at 9:48 AM
Corvus Pharmaceuticals Announces Proposed Public Offering of Common StockCorvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 11 at 6:30 PM
Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Down 13%Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Down 13%
americanbankingnews.com - February 10 at 9:02 PM
Top Analyst Upgrades and Downgrades: Akamai, Avaya, Canopy Growth, Corsair Gaming, Playtika, Virgin Galactic and MoreTop Analyst Upgrades and Downgrades: Akamai, Avaya, Canopy Growth, Corsair Gaming, Playtika, Virgin Galactic and More
msn.com - February 10 at 9:33 AM
Mizuho Downgrades Corvus Pharmaceuticals (NASDAQ:CRVS) to NeutralMizuho Downgrades Corvus Pharmaceuticals (NASDAQ:CRVS) to Neutral
americanbankingnews.com - February 10 at 7:46 AM
Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 11.4%Corvus Pharmaceuticals (NASDAQ:CRVS) Trading Up 11.4%
americanbankingnews.com - February 9 at 7:40 PM
Corvus Initiates CPI-006 Pivotal Trial In COVID-19 Patients; Results Expected by 2021 EndCorvus Initiates CPI-006 Pivotal Trial In COVID-19 Patients; Results Expected by 2021 End
finance.yahoo.com - February 4 at 3:16 PM
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
finance.yahoo.com - February 4 at 10:15 AM
What Type Of Shareholders Make Up Corvus Pharmaceuticals, Inc.s (NASDAQ:CRVS) Share Registry?What Type Of Shareholders Make Up Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Share Registry?
finance.yahoo.com - January 30 at 9:28 AM
Is CRVS A Good Stock To Buy Now?Is CRVS A Good Stock To Buy Now?
finance.yahoo.com - December 7 at 5:34 PM
Corvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & ExpositionCorvus Presents New Data on its Investigational ITK Inhibitor CPI-818 at the American Society of Hematology (ASH) Annual Meeting & Exposition
finance.yahoo.com - December 6 at 12:16 PM
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & ExpositionCorvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
finance.yahoo.com - November 30 at 12:31 PM
Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual MeetingCorvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
finance.yahoo.com - November 11 at 7:55 PM
Corvus immunotherapy shows durable benefit in COVID-19Corvus' immunotherapy shows durable benefit in COVID-19
seekingalpha.com - November 9 at 12:39 PM
Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingCorvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - November 9 at 12:39 PM
Corvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Session at the 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingCorvus Pharmaceuticals COVID-19 Abstract Selected for “Hot Topic” Oral Session at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - November 2 at 2:33 PM
We Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth CarefullyWe Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth Carefully
finance.yahoo.com - November 1 at 12:46 PM
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - October 29 at 7:17 PM
Corvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for Patients with COVID-19 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingCorvus Pharmaceuticals to Present Updated Data from its Clinical Trial of CPI-006 for Patients with COVID-19 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - October 29 at 9:16 AM
Corvus Shares Surge After Positive Data From Early Stage Study On COVID-19 TreatmentCorvus Shares Surge After Positive Data From Early Stage Study On COVID-19 Treatment
nasdaq.com - October 7 at 5:35 PM
Corvus Pharma rallies 40% on promising CPI-006 data in COVID-19Corvus Pharma rallies 40% on promising CPI-006 data in COVID-19
seekingalpha.com - October 5 at 1:11 PM
Corvus Shareholders Must Be Happy With This COVID-19 Study UpdateCorvus Shareholders Must Be Happy With This COVID-19 Study Update
msn.com - October 5 at 1:11 PM
Stock Alert: Corvus Rise 30% On Positive Data From Early COVID Treatment StudyStock Alert: Corvus Rise 30% On Positive Data From Early COVID Treatment Study
nasdaq.com - October 5 at 1:11 PM
Why Corvus Pharmaceuticals Is Trading Higher TodayWhy Corvus Pharmaceuticals Is Trading Higher Today
msn.com - October 5 at 1:11 PM
Shares of Corvus jump on additional data from small Phase 1 trial for COVID-19 treatmentShares of Corvus jump on additional data from small Phase 1 trial for COVID-19 treatment
msn.com - October 5 at 8:10 AM
Corvus rallies on co-founding China-based Angel PharmaceuticalsCorvus rallies on co-founding China-based Angel Pharmaceuticals
seekingalpha.com - October 5 at 8:10 AM
Corvus To Initially Retain 49.7% Stake In Angel Pharma - Quick FactsCorvus To Initially Retain 49.7% Stake In Angel Pharma - Quick Facts
nasdaq.com - October 5 at 8:10 AM
New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020
finance.yahoo.com - September 17 at 5:07 AM
Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of DirectorsCorvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors
finance.yahoo.com - September 11 at 12:18 PM
Corvus Pharma +10% on encouraging CPI-006 data in COVID-19Corvus Pharma +10% on encouraging CPI-006 data in COVID-19
seekingalpha.com - September 10 at 10:09 AM
Corvus Pharma Updates On Clinical Trial Of CPI-006 For Patients With COVID-19 - Quick FactsCorvus Pharma Updates On Clinical Trial Of CPI-006 For Patients With COVID-19 - Quick Facts
nasdaq.com - September 10 at 10:09 AM
Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19
finance.yahoo.com - September 10 at 10:09 AM
Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceCorvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 4 at 8:46 PM
How Much Of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Do Insiders Own?How Much Of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Do Insiders Own?
finance.yahoo.com - August 3 at 1:30 PM
Corvus Pharmaceuticals EPS misses by $0.06Corvus Pharmaceuticals EPS misses by $0.06
seekingalpha.com - July 30 at 6:43 PM
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial ResultsCorvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
finance.yahoo.com - July 30 at 6:43 PM
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020
finance.yahoo.com - July 23 at 10:12 AM
Novo Holdings sells 1.54M shares in Corvus PharmaceuticalsNovo Holdings sells 1.54M shares in Corvus Pharmaceuticals
seekingalpha.com - July 10 at 11:20 AM
Corvus Pharmaceuticals (CRVS) Catches Eye: Stock Jumps 8.4%Corvus Pharmaceuticals (CRVS) Catches Eye: Stock Jumps 8.4%
finance.yahoo.com - July 9 at 12:38 PM
Why This Analyst Sees Big Upside in COVID-19 Immunotherapy StudyWhy This Analyst Sees Big Upside in COVID-19 Immunotherapy Study
247wallst.com - July 8 at 1:02 PM
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.